EPLAW PATENT BLOG

UK – Sony Communications International v. SSH Communications Security Corporation

Posted: October 24th, 2016

Sony Communications International AB and others v SSH Communications Security Corporation and others, UK Patents Court, Roger Wyand QC, 10 October 2016, Neutral Citation Number: [2016] EWHC 2359 (Ch) In this action Sony sought to revoke SSH’s patent, EP (UK) 2 254 311. This patent related to an aspect of accessing wide area networks (WANs) […]

READ MORE

UK – Warner-Lambert v. Actavis

Posted: October 17th, 2016

Warner-Lambert Company LLC v (1) Generics (UK) Limited (trading as Mylan), (2) Actavis Group PTC EHF, (3) Actavis UK Limited and (4) Caduceus Pharma Limited, England and Wales Court of Appeal (Floyd, Pattern and Kitchin LJJ), London UK, 13 October 2016, Neutral Citation Number: [2016] EWCA Civ 1006 The Court of Appeal dismissed Warner-Lambert’s appeal […]

READ MORE

NL – VWS v. Ventraco et al

Posted: September 7th, 2016

District Court The Hague 27 July 2016, C/09/485397 / HA-ZA 15-366 (VWS vs. Ventraco et al) VWS owns a European patent, EP 2 389 415 B1 (“EP 415”), in which a method for rejuvenating a bitumen containing composition (such as asphalt) is claimed. The method according to claim 1 comprises, amongst other features, a distillation […]

READ MORE

UK – Actavis v. ICOS

Posted: August 22nd, 2016

Actavis Group PTC EHF, Actavis UK Ltd, Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals UK Limited, Teva UK Limited, Teva Pharmaceutical Industries Limited & Generics (UK) Limited (Trading as Mylan) v ICOS Corporation & Eli Lilly and Company. England and Wales Patents Court (Birss J), London, UK, 10 August 2016, Neutral Citation Number: [2016] EWHC 1955 (Pat) […]

READ MORE

UK – Napp v. Dr Reddy’s / Sandoz

Posted: August 3rd, 2016

Napp Pharmaceutical Holdings Limited v (1) Dr Reddy’s Laboratories (UK) Limited (2) Sandoz Limited. UK Patents Court (Arnold J). Case neutral citation number: [2016] EWHC 1517 (Pat) In a decision that considers both numerical ranges and de minimis patent infringement, the UK Patents Court has held that products (7 day buprenorphine transdermal patches) proposed to […]

READ MORE

NL – Novartis v. Alvogen and Focus Farma

Posted: July 12th, 2016

Novartis AG v. Alvogen IPCO S.a.r.l and Focus Farma, District Court The Hague, the Netherlands, 6 July 2016, Case no. ECLI:NL:RBDHA:2016:7502 On 6 July 2016 the The Hague District Court rejected Novartis’ claim against Alvogen and Focus Farma based on infringement of its patent for patches containing rivastigmine, as it held the patent to be […]

READ MORE

ES – MSD v. Química Sintética & Chemo Ibérica / Losartan / Supreme Court

Posted: June 29th, 2016

Merck Sharp & Dohme de España, S.A. v. Química Sintética, S.A. & Chemo Ibérica, S.A., Supreme Court (Civil Chamber, 1st Section), Spain, 2 March 2016, Docket No. 2206/2013 The Spanish Supreme Court definitely ruled in the long-term patent litigation initiated back in 2005 by MSD against the companies Química Sintética and Chemo Ibérica in relation […]

READ MORE

UK – GlaxoSmithKline v Wyeth Holdings

Posted: May 20th, 2016

GlaxoSmithKline UK Limited v Wyeth Holdings LLC, High Court of Justice of England & Wales (Patents Court), London, UK, Carr J, 12 May 2016, Neutral Citation Number: [2016] EWHC 1045 (CH) Carr J has upheld the validity of Wyeth’s patent EP(UK) 2,343,308 relating to a combination product comprising a 2086 protein and a PorA protein […]

READ MORE

UK – Saertex v. Hexcel

Posted: May 17th, 2016

Saertex France SAS v Hexcel Reinforcements UK Limited (formerly Formax (UK) Limited, High Court of Justice of England and Wales, Intellectual Property and Enterprise Court (HHJ Hacon), London UK, 4 May 2016, Neutral Citation Number: [2016] EWHC 966 (IPEC) This case concerned Saertex’s claim that its patent for a method of manufacturing fibre-based reinforcements was […]

READ MORE